US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
DICE Therapeutics Inc (DICE)
DICE Therapeutics Inc (DICE) ニュース

DICE

DICE Therapeutics (DICE)

DICE Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:DICE

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/08/21	21 : 00	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/11	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/10	05 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/10	05 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/10	05 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/10	05 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/10	05 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/10	05 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/09	22 : 47	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/09	22 : 45	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/09	22 : 42	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/09	22 : 38	Edgar (US Regulatory)	Form POSASR - Post-effective Amendment to an automatic shelf registration statement	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/09	22 : 32	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/09	22 : 26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/09	22 : 20	Edgar (US Regulatory)	Form SC 14D9/A - Solicitation, recommendation statements: [Amend]	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/09	22 : 02	PR Newswire (US)	Lilly Completes Acquisition of DICE Therapeutics	NASDAQ:DICE	DICE Therapeutics Inc
2023/08/09	05 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:DICE	DICE Therapeutics Inc
2023/07/25	20 : 11	Edgar (US Regulatory)	Form SC 14D9/A - Solicitation, recommendation statements: [Amend]	NASDAQ:DICE	DICE Therapeutics Inc
2023/07/25	19 : 55	PR Newswire (US)	Lilly Announces Extension of Tender Offer to Acquire DICE	NASDAQ:DICE	DICE Therapeutics Inc
2023/07/18	06 : 23	Edgar (US Regulatory)	Form SC 14D9/A - Solicitation, recommendation statements: [Amend]	NASDAQ:DICE	DICE Therapeutics Inc
2023/07/01	05 : 22	Edgar (US Regulatory)	Form SC 14D9 - Solicitation, recommendation statements	NASDAQ:DICE	DICE Therapeutics Inc
2023/06/24	06 : 37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DICE	DICE Therapeutics Inc
2023/06/24	06 : 11	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:DICE	DICE Therapeutics Inc
2023/06/23	05 : 33	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:DICE	DICE Therapeutics Inc
2023/06/22	06 : 01	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:DICE	DICE Therapeutics Inc
2023/06/21	05 : 07	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:DICE	DICE Therapeutics Inc
2023/06/20	23 : 15	Dow Jones News	Trending: Eli Lilly Buys DICE Therapeutics in Deal Worth $2.4 Billion	NASDAQ:DICE	DICE Therapeutics Inc
2023/06/20	21 : 21	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:DICE	DICE Therapeutics Inc
2023/06/20	20 : 42	Dow Jones News	Eli Lilly to Acquire DICE Therapeutics for $2.4 Billion	NASDAQ:DICE	DICE Therapeutics Inc
2023/06/20	20 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DICE	DICE Therapeutics Inc

Showing the most relevant articles for your search:NASDAQ:DICE

1 2 3 4 次へ >>

Grange Resources

Ecuador Gold and Copper Corp.

BNP Paribas Issuance

MediBloc [Ethereum]

BNP Paribas Issuance

Vontobel Financial Produ...

AMMB Holdings BHD (PK)

ITUBX401 Ex:38,45

Cboe Vest Large Cap Deep...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約